Onishi S - Search Results

1

CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients.

Ohnishi T, Ogawa Y, Saibara T, Nishioka A, Kariya S, Fukumoto M, Onishi S, Yoshida S. Ohnishi T, et al. Among authors: onishi s. Oncol Rep. 2005 Mar;13(3):485-9. Oncol Rep. 2005. PMID: 15706422 Clinical Trial.

2

Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen.

Nemoto Y, Saibara T, Ogawa Y, Zhang T, Xu N, Ono M, Akisawa N, Iwasaki S, Maeda T, Onishi S. Nemoto Y, et al. Among authors: onishi s. Intern Med. 2002 May;41(5):345-50. doi: 10.2169/internalmedicine.41.345. Intern Med. 2002. PMID: 12058881 Free article.

3

Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.

Murata Y, Ogawa Y, Saibara T, Nishioka A, Takeuchi N, Kariya S, Onishi S, Yoshida S. Murata Y, et al. Among authors: onishi s. Oncol Rep. 2003 Jan-Feb;10(1):97-100. Oncol Rep. 2003. PMID: 12469151

4

[Drug-induced NASH].

Saibara T, Onishi S. Saibara T, et al. Among authors: onishi s. Nihon Rinsho. 2006 Jun;64(6):1100-5. Nihon Rinsho. 2006. PMID: 16768116 Review. Japanese.

5

CYP17 polymorphism and tamoxifen-induced hepatic steatosis.

Ohnishi T, Ogawa Y, Saibara T, Nishioka A, Kariya S, Fukumoto M, Onishi S, Yoshida S. Ohnishi T, et al. Among authors: onishi s. Hepatol Res. 2005 Oct;33(2):178-80. doi: 10.1016/j.hepres.2005.09.030. Hepatol Res. 2005. PMID: 16890174

6

In vivo imaging of hepatic fatty acid metabolism in patients with non-alcoholic steatohepatitis using semiquantitative 123I-labeled branched-chain fatty acid analog.

Onishi S, Saibara T. Onishi S, et al. J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S76-8. doi: 10.1111/j.1440-1746.2006.04572.x. J Gastroenterol Hepatol. 2006. PMID: 16958679 Review.

7

Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.

Murata Y, Ogawa Y, Saibara T, Nishioka A, Fujiwara Y, Fukumoto M, Inomata T, Enzan H, Onishi S, Yoshida S. Murata Y, et al. Among authors: onishi s. Oncol Rep. 2000 Nov-Dec;7(6):1299-304. doi: 10.3892/or.7.6.1299. Oncol Rep. 2000. PMID: 11032933 Clinical Trial.

8

[Nonalcoholic steatohepatitis (NASH)].

Saibara T, Onishi S. Saibara T, et al. Among authors: onishi s. Nihon Shokakibyo Gakkai Zasshi. 2002 Jun;99(6):570-6. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12099001 Japanese. No abstract available.

9

[NASH and metabolic syndrome].

Saibara T, Ono M, Onishi S. Saibara T, et al. Among authors: onishi s. Nihon Rinsho. 2006 Jun;64(6):1165-7. Nihon Rinsho. 2006. PMID: 16768126 Review. Japanese.

10

In vivo imaging of hepatic fatty acid metabolism in patients with nonalcoholic steatohepatitis using semiquantative (123)I-BMIPP liver scan.

Fukumoto M, Masuda K, Ogawa Y, Nishioka A, Ohnishi T, Murata Y, Yoshida S, Ono M, Saibara T, Onishi S. Fukumoto M, et al. Among authors: onishi s. Hepatol Res. 2005 Oct;33(2):105-9. doi: 10.1016/j.hepres.2005.09.015. Hepatol Res. 2005. PMID: 16890172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

947 results

Search Page

Filters